Page 175 - Read Online

Cheng et al. Advances in liver fibrosis

of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a Ma TM, Wong BC, Wong VW. Measuring spleen stiffness to predict
meta-analysis. PLoS One 2014;9:e92772. varices in chronic hepatitis B cirrhotic patients with or without
74. Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. receiving non-selective beta-blockers. J Dig Dis 2016;17:538-46.
The Enhanced Liver Fibrosis (ELF) score: normal values, influence 89. Wong GL, Kwok R, Hui AJ, Chan HL, Wong VW. A new screening
factors and proposed cut-off values. J Hepatol 2013;59:236-42. strategy for varices based on liver and spleen stiffness measurement
75. Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, (LSSM) in cirrhotic patients: a randomized controlled trial. J Hepatol
Grunfeld C, Rosenberg WM, Peters MG, Tien PC. Association of 2017;66:S79.
HIV, hepatitis C virus, and liver fibrosis severity with the enhanced 90. Pang Q, Zhang JY, Xu XS, Song SD, Chen W, Zhou YY, Miao
liver fibrosis score. J Infect Dis 2016;213:1079-86. RC, Qu K, Liu SS, Dong YF, Liu C. The prognostic values of 12
76. Toshima T, Shirabe K, Ikegami T, Yoshizumi T, Kuno A, Togayachi cirrhosis-relative noninvasive models in patients with hepatocellular
A, Gotoh M, Narimatsu H, Korenaga M, Mizokami M, Nishie A, carcinoma. Scand J Clin Lab Invest 2015;75:73-84.
Aishima S, Maehara Y. A novel serum marker, glycosylated Wisteria 91. Wong JS, Wong GL, Chan AW, Wong VW, Cheung YS, Chong CC,
floribunda agglutinin-positive Mac-2 binding protein (WFA(+)- Wong J, Lee KF, Chan HL, Lai PB. Liver stiffness measurement by
M2BP), for assessing liver fibrosis. J Gastroenterol 2015;50:76-84. transient elastography as a predictor on posthepatectomy outcomes.
77. Zou X, Zhu MY, Yu DM, Li W, Zhang DH, Lu FJ, Gong QM, Liu Ann Surg 2013;257:922-8.
F, Jiang JH, Zheng MH, Kuno A, Narimatsu H, Zhang Y, Zhang XX. 92. de Ledinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, Le Bail
Serum WFA+ -M2BP levels for evaluation of early stages of liver B, Merrouche W, Bernard PH. Non-invasive tests for fibrosis and liver
fibrosis in patients with chronic hepatitis B virus infection. Liver Int stiffness predict 5-year survival of patients chronically infected with
2017;37:35-44. hepatitis B virus. Aliment Pharmacol Ther 2013;37:979-88.
78. Tao H, Yang JJ, Shi KH, Huang C, Zhang L, Lv XW, Li J. The 93. Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B,
significance of YKL-40 protein in liver fibrosis. Inflamm Res Merrouche W, Couzigou P, de Ledinghen V. Noninvasive tests for
2014;63:249-54. fibrosis and liver stiffness predict 5-year outcomes of patients with
79. Kumagai E, Mano Y, Yoshio S, Shoji H, Sugiyama M, Korenaga M, chronic hepatitis C. Gastroenterology 2011;140:1970-9, 9 e1-3.
Ishida T, Arai T, Itokawa N, Atsukawa M, Hyogo H, Chayama K, 94. Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-
Ohashi T, Ito K, Yoneda M, Kawaguchi T, Torimura T, Nozaki Y, Hubert I, Oberti F, Rousselet MC, Cales P. Combination of blood
Watanabe S, Mizokami M, Kanto T. Serum YKL-40 as a marker of tests for significant fibrosis and cirrhosis improves the assessment
liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep of liver-prognosis in chronic hepatitis C. Aliment Pharmacol Ther
2016;6:35282. 2014;40:178-88.
80. Trembling PM, Lampertico P, Parkes J, Tanwar S, Vigano M, 95. Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygard S, Godang K,
Facchetti F, Colombo M, Rosenberg WM. Performance of Enhanced Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH,
Liver Fibrosis test and comparison with transient elastography in Lund-Johansen F, Syversveen T, Brabrand K, Pares A, Ponsioen CY,
the identification of liver fibrosis in patients with chronic hepatitis B Pinzani M, Farkkila M, Moum B, Ueland T, Rosjo H, Rosenberg
infection. J Viral Hepat 2014;21:430-8. W, Boberg KM, Karlsen TH. Enhanced liver fibrosis score predicts
81. Wong GL, Chan HL, Yu Z, Wong CK, Leung C, Ho PP, Chan CY, transplant-free survival in primary sclerosing cholangitis. Hepatology
Chung VC, Chan ZC, Tse YK, Chim AM, Lau TK, Chan HY, Tse CH, 2015;62:188-97.
Wong VW. Noninvasive assessments of liver fibrosis with transient 96. Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey
elastography and Hui index predict survival in patients with chronic MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J,
hepatitis B. J Gastroenterol Hepatol 2015;30:582-90. Rosenberg W. Enhanced liver fibrosis marker as a noninvasive
82. Wong GL, Wong VW, Choi PC, Chan AW, Chan HL. Development predictor of mortality in HIV/hepatitis C virus-coinfected women
of a non-invasive algorithm with transient elastography (Fibroscan) from a multicenter study of women with or at risk for HIV. AIDS
and serum test formula for advanced liver fibrosis in chronic hepatitis 2016;30:723-9.
B. Aliment Pharmacol Ther 2010;31:1095-103. 97. Shuang-Ming T, Ping Z, Ying Q, Li-Rong C, Ping Z, Rui-Zhen
83. Crisan D, Radu C, Lupsor M, Sparchez Z, Grigorescu MD, Grigorescu L. Usefulness of acoustic radiation force impulse imaging in the
M. Two or more synchronous combination of noninvasive tests to differential diagnosis of benign and malignant liver lesions. Acad
increase accuracy of liver fibrosis assessement in chronic hepatitis C; Radiol 2011;18:810-5.
results from a cohort of 446 patients. Hepat Mon 2012;12:177-84. 98. Garteiser P, Doblas S, Daire JL, Wagner M, Leitao H, Vilgrain V,
84. Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol Sinkus R, Van Beers BE. MR elastography of liver tumours: value
J, France J, Trifan A, Lenaour G, Vaillant JC, Ratziu V, Charlotte of viscoelastic properties for tumour characterisation. Eur Radiol
F; Fibrosis-TAGS group. Performances of Elasto-FibroTest((R)), a 2012;22:2169-77.
combination between FibroTest((R)) and liver stiffness measurements 99. Wong GL, Chan HL, Wong CK, Leung C, Chan CY, Ho PP, Chung
for assessing the stage of liver fibrosis in patients with chronic hepatitis VC, Chan ZC, Tse YK, Chim AM, Lau TK, Wong VW. Liver
C. Clin Res Hepatol Gastroenterol 2012;36:455-63. stiffness-based optimization of hepatocellular carcinoma risk score in
85. Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and patients with chronic hepatitis B. J Hepatol 2014;60:339-45.
hepatic stellate cells: Etiology, pathological hallmarks and therapeutic 100. Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche
targets. World J Gastroenterol 2016;22:10512-22. W, Colombo M, Thibault V, Schiff E, Brass CA, Albrecht JK, Rudler
86. Sun XL, Liang LW, Cao H, Men Q, Hou KZ, Chen Z, Zhao YE. M, Deckmyn O, Lebray P, Thabut D, Ratziu V, de Ledinghen V,
Liver reserve function assessment by acoustic radiation force impulse FibroFrance Study G, Epic3 Study G, Bordeaux HCVSG. Staging
imaging. World J Gastroenterol 2015;21:9648-55. chronic hepatitis C in seven categories using fibrosis biomarker
87. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, (FibroTest) and transient elastography (FibroScan(R)). J Hepatol
Enomoto N. Association of splenic MR elastographic findings with 2014;60:706-14.
gastroesophageal varices in patients with chronic liver disease. J 101. Kim BK, Kim HS, Yoo EJ, Oh EJ, Park JY, Kim DY, Ahn SH, Han
Magn Reson Imaging 2015;41:117-24. KH, Kim SU, Park YN. Risk assessment of clinical outcomes in Asian
88. Wong GL, Kwok R, Chan HL, Tang SP, Lee E, Lam TC, Lau TW, patients with chronic hepatitis B using enhanced liver fibrosis test.
Hepatoma Research ¦ Volume 3 ¦ August 08, 2017 167